REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 11th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec
This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 4, 2024, between Mangoceuticals, Inc. (the “Company”), a corporation organized under the laws of the State of Texas, and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
COMMON SHARE PURCHASE WARRANTCommon Share Purchase Warrant • April 11th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Platinum Point Capital LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 4, 2024 (as defined in the Purchase Agreement) has been received (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of such Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Mangoceuticals, Inc., a corporation incorporated under the laws of the State of Texas (the “Company”), up to 3,300,000 (as subject to adjustment hereunder, the “Warrant Shares”) Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 11th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 4, 2024, between Mangoceuticals, Inc. (the “Corporation” or “Company”), a corporation organized under the laws of the State of Texas (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • April 11th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec • New York
THIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is entered into as of April 4, 2024 (the “Execution Date”), by and between Mangoceuticals, Inc., a corporation organized under the laws of the State of Texas (the “Company”), and Platinum Point Capital LLC, a Nevada limited liability company (the “Investor”).
